Module 2 is enriched for several carcinogenic signatures, including “top genes down‐regulated in metastatic versus non‐metastatic bladder cancer cell lines” and “genes up‐regulated in primary melanoma, sensitive to TRAIL compared to metastatic melanoma, resistant to TRAIL” (Figure 4F; Table S6). This evidence concerns the gene TNFSF10 and urinary bladder cancer.